Figure S1 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response

Key Points

• B7-H3 CAR T cells demonstrate significant effectiveness against ependymomas.
• Tumor size was identified as a limiting factor in the efficacy of B7-H3 CAR T cells.
• Immune response also significantly impacts the effectiveness of B7-H3 CAR T cell therapy.
• The findings highlight the need for strategies to enhance CAR T cell effectiveness in larger tumors.